cardiovascular
side effects
deep vein thrombosis
hypertension
hypotension
myocardial infarction
pulmonary embolism
tachycardia
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
dermatologic side effects
alopecia
rash
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
postmarketing
postmarketing side effects
pruritus
rash
urticaria
stevens-johnson syndrome/toxic epidermal necrolysis
gastrointestinal side effects
nausea
constipation
diarrhea
dyspepsia
vomiting
stomatitis
heartburn
gastritis
epigastric discomfort
use of aprepitant as a part of a regimen with ondansetron
dexamethasone
emetogenic cancer chemotherapy
acid reflux
deglutination
disorder
dysgeusia
dysphagia
flatulence
obstipation
salivation
taste disturbance
general
side effects
asthenia/fatigue
dizziness
dehydration
abdominal pain
fever
mucous membrane disorder
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
diaphoresis
edema
flushing
malaise
pelvic pain
septic shock
upper respiratory infection
common side effects
incidence
hiccups
asthenia/fatigue
alt
ast
constipation
dyspepsia
diarrhea
headache
anorexia
genitourinary side effects
dysuria
renal insufficiency
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
hematologic side effects
neutropenia
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
anemia
febrile neutropenia
thrombocytopenia
hypersensitivity side effects
anaphylactic reactions
metabolic side effects
diabetes mellitus
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
decreased appetite
hypokalemia
weight loss
musculoskeletal side effects
muscular weakness
musculoskeletal pain
myalgia
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
nervous system
side effects
headache
insomnia
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
peripheral neuropathy
sensory neuropathy
other side effects
anorexia
tinnitus
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
thyroid
follicular cell adenomas
carcinomas in male rats
incidences of hepatocellular adenoma
thyroid
follicular adenoma in female rats
drug
skin fibrosarcomas in male mice
oncologic side effects
malignant neoplasm
non-small cell lung carcinoma
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
psychiatric side effects
anxiety disorder
confusion
depression
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
respiratory side effects
hiccups
use of aprepitant as a part of a regimen
ondansetron
dexamethasone
emetogenic cancer chemotherapy
cough
dyspnea
pneumonitis
respiratory insufficiency
lower respiratory infection
nasal secretion
pharyngitis
pharyngolaryngeal pain
vocal disturbance
tarry stools
chills
cough
fever
side pain
difficult urination
pale skin
shortness of breath
sore throat
ulcers
sores
white spots in the mouth
unusual bleeding
bruising
unusual tiredness
weakness
blistering
peeling
loosening of the skin
confusion about identity
place
time
diarrhea
itching
skin rash
muscle pain
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
redness of the skin
red, irritated eyes
red skin lesions
purple center
irregular heartbeat
acid
sour stomach
belching
confusion
decreased urination
dizziness
dry mouth
fainting
heartburn
hiccups
increase in heart rate
indigestion
lack
loss of strength
lightheadedness
loss of appetite
nausea
rapid breathing
stomach discomfort upset
pain
sunken eyes
swelling
inflammation of the mouth
thirst
weight loss
wrinkled skin
burning feeling in the chest
stomach
hot flashes
indigestion
pain
discomfort in the chest
upper stomach
throat
tenderness in the stomach area